Literature DB >> 31564581

Cerebrospinal fluid drainage complications during first stage and completion fenestrated-branched endovascular aortic repair.

Jussi M Kärkkäinen1, Nolan C Cirillo-Penn1, Indrani Sen1, Emanuel R Tenorio1, William J Mauermann2, George D Gilkey2, Timothy J Kaufmann3, Gustavo S Oderich4.   

Abstract

OBJECTIVE: To determine the rates and risk factors of complications related to cerebrospinal fluid drainage (CSFD) during first stage and completion fenestrated-branched endovascular aortic repair (F-BEVAR) of pararenal and thoracoabdominal aortic aneurysms.
METHODS: We reviewed the outcomes of 293 consecutive patients enrolled in a prospective, nonrandomized study to investigate outcomes of F-BEVAR between 2013 and 2018. Patients who received CSFD during first-stage thoracic endovascular aortic repair, index F-BEVAR, or completion of temporary aneurysm sac perfusion procedures were included in the analysis. CSFD complications were graded as severe or moderate if they were life threatening, escalated the level of care, or prolonged the hospital stay. Presence of substantial degenerative lumbar disease (DLD) was identified based on review of preoperative computed tomography. End points included technical difficulties during CSFD placement and CSFD-related complications.
RESULTS: A total of 187 patients (mean age, 73 ± 8 years; 70% male) treated for 20 pararenal and 167 thoracoabdominal aortic aneurysms received CSFD in 240 procedures, including 51 first-stage thoracic endovascular aortic repairs, 184 index F-BEVARs, and 5 completion temporary aneurysm sac perfusion procedures. Nineteen patients (10%) had 22 CSFD-related complications after 21 aortic procedures (9%). Complications were graded as severe to moderate in 17 patients (9%). There were 12 patients (6%) with intracranial hypotension, including three (2%) who had intracranial hemorrhage and nine (5%) with post dural puncture headache requiring blood patches in six. Another six patients (3%) developed spinal hematomas resulting in paraplegia in two (1%) and transient paraparesis in two (1%). One patient had CSF leakage from the puncture site (no intervention required). Four patients had bleeding during attempted drain placement, which required postponement of F-BEVAR. Technical difficulties were experienced in 57 drain insertions (24%), more often in patients with DLD than in those without DLD (35/113 [31%] vs 22/121 [18%]; P = .03). Fluoroscopic guidance was used in 44 drain placements (18%) with a lower rate of technical difficulties compared with the blind approach (9% vs 28%; P = .01). There was a statistically nonsignificant trend toward more complications in patients with technical challenges (14% vs 7%; P = .10). Of 13 study patients who developed spinal cord injuries during aortic procedures, 4 (31%) were attributed to CSFD.
CONCLUSIONS: Although CSFD is widely used to prevent ischemic spinal cord injury during complex aortic repair, the risk of major CSFD-related complications is not negligible and should be carefully weighed against its potential benefits. One-third of spinal cord injuries were caused by CSF drain placement. The use of fluoroscopic guidance may decrease the risk of CSFD-related complications.
Copyright © 2019 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Branched; Cerebrospinal fluid drainage; Endovascular aortic repair; Fenestrated; Spinal cord injury; Spinal drain

Year:  2019        PMID: 31564581     DOI: 10.1016/j.jvs.2019.06.210

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

1.  Simultaneous Endovascular Repair Is Not Associated With Increased Risk for Thoracic and Abdominal Aortic Pathologies: Early and Midterm Outcomes.

Authors:  Weichang Zhang; Lei Zhang; Xin Li; Ming Li; Jian Qiu; Mo Wang; Chang Shu
Journal:  Front Cardiovasc Med       Date:  2022-05-27

2.  Strategies to prevent and detect intraoperative spinal cord ischemia during complex aortic surgery: from drainages and biomarkers.

Authors:  Alexander Gombert; Florian Simon
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

3.  Safety of cerebrospinal fluid drainage for spinal cord ischemia prevention in thoracic endovascular aortic repair.

Authors:  John R Spratt; Kristen L Walker; Tyler J Wallen; Dan Neal; Yury Zasimovich; George J Arnaoutakis; Tomas D Martin; Martin R Back; Salvatore T Scali; Thomas M Beaver
Journal:  JTCVS Tech       Date:  2022-05-11

Review 4.  Postoperative Intensive Care Management of Aortic Repair.

Authors:  Stefano De Paulis; Gabriella Arlotta; Maria Calabrese; Filippo Corsi; Temistocle Taccheri; Maria Enrica Antoniucci; Lorenzo Martinelli; Francesca Bevilacqua; Giovanni Tinelli; Franco Cavaliere
Journal:  J Pers Med       Date:  2022-08-22

Review 5.  Peri-Operative Management of Patients Undergoing Fenestrated-Branched Endovascular Repair for Juxtarenal, Pararenal and Thoracoabdominal Aortic Aneurysms: Preventing, Recognizing and Treating Complications to Improve Clinical Outcomes.

Authors:  Andrea Xodo; Mario D'Oria; Bernardo Mendes; Luca Bertoglio; Kevin Mani; Mauro Gargiulo; Jacob Budtz-Lilly; Michele Antonello; Gian Franco Veraldi; Fabio Pilon; Domenico Milite; Cristiano Calvagna; Filippo Griselli; Jacopo Taglialavoro; Silvia Bassini; Anders Wanhainen; David Lindstrom; Enrico Gallitto; Luca Mezzetto; Davide Mastrorilli; Sandro Lepidi; Randall DeMartino
Journal:  J Pers Med       Date:  2022-06-21

6.  Pneumocephalus in thoracoabdominal aortic aneurysm repair after lumbar drain removal and blood patch.

Authors:  Jack Bontekoe; Kyla Bennett
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-05-05

7.  Intercostal artery incorporation to prevent spinal cord ischemia during total endovascular thoracoabdominal aortic repair.

Authors:  Anastasia Plotkin; Sukgu M Han; Miguel F Manzur; Mark J Cunningham; Fernando Fleischman; Gregory A Magee
Journal:  JTCVS Tech       Date:  2021-01-28

8.  Commentary: Protecting the artery of Adamkiewicz: Highest imperative.

Authors:  Matheus P Falasa; Salvatore T Scali; Thomas M Beaver
Journal:  JTCVS Tech       Date:  2021-02-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.